Federated GAN

The core mechanism where a generator and discriminator are trained across multiple institutions. Each client trains a local discriminator on private data, while the generator can be global or shared. Key aspects:

• Local discriminators learn site-specific data distributions
• Generator updates are aggregated via federated averaging
• No raw patient data leaves the institution
• Adversarial loss is computed locally and gradients are shared
• Prevents membership inference attacks by design

Federated GANs produce synthetic patient records that statistically mirror real clinical data without memorizing individual samples. Capabilities include:

• Generating realistic EHR sequences with temporal dependencies
• Creating synthetic medical images for rare disease augmentation
• Preserving column-wise distributions in tabular clinical data
• Enabling Train-Synthetic-Test-Real (TSTR) validation paradigms
• Supporting synthetic control arms for clinical trials
• Differential privacy noise can be injected during aggregation for formal guarantees

Federated GANs are specifically designed to address non-IID data distributions across clinical sites. Each hospital may have different patient demographics, equipment, and coding practices. Mitigation strategies:

• Conditional GAN architectures that model site-specific covariates
• Federated normalization to align feature scales without data sharing
• Local discriminators that adapt to site-specific distributional shifts
• Consistency regularization to enforce stable generation across nodes
• Handling of Missing Not At Random (MNAR) patterns via federated imputation

Domain-specific variants optimized for clinical data modalities. Notable implementations:

• medGAN: Optimized for high-dimensional discrete EHR data with autoencoder preprocessing
• CTGAN: Handles mixed discrete and continuous columns in tabular patient records
• Federated Conditional GANs: Generate data conditioned on specific disease phenotypes
• Time-series GANs: Synthesize longitudinal patient trajectories across visits
• Multi-modal federated GANs: Jointly generate imaging and structured clinical data
• These architectures integrate with FHIR standards for interoperability

Federated GANs face unique adversarial threats that must be mitigated. Primary concerns:

• Model inversion attacks: Attempting to reconstruct training data from shared gradients
• Data poisoning: Malicious clients injecting corrupted samples to degrade generation quality
• GAN-specific leakage: The discriminator may inadvertently encode private information
• Defense mechanisms include gradient clipping, secure aggregation, and differential privacy
• Byzantine fault tolerance ensures robustness against failing or adversarial nodes
• Federated data lineage tracking provides audit trails for all generated samples

Rigorous metrics ensure synthetic data maintains clinical validity without compromising privacy. Evaluation approaches:

• Synthetic Data Utility scores measuring statistical fidelity to real distributions
• TSTR (Train-Synthetic-Test-Real) paradigm for downstream task validation
• K-Anonymity and differential privacy budget tracking across training rounds
• Distributional shift detection to monitor concept drift in generated samples
• Federated stratified sampling ensures demographic representation
• Cross-site schema drift detection prevents structural inconsistencies

The foundational dual-network architecture where a generator creates synthetic data and a discriminator evaluates authenticity. In a GAN, these networks engage in a minimax game—the generator learns to produce increasingly realistic samples while the discriminator improves at detecting fakes. This adversarial dynamic drives the generation of high-fidelity synthetic patient records, medical images, or genomic sequences that preserve statistical properties without exposing real individuals.

A mathematical framework providing provable privacy guarantees by injecting calibrated noise into model updates or generated outputs. In Federated GANs, differential privacy ensures that synthetic samples cannot be reverse-engineered to reveal individual patient records. Key mechanisms include:

• Epsilon (ε) parameter: Controls the privacy-utility tradeoff
• Gaussian noise injection: Added to discriminator gradients during training
• Privacy budget tracking: Monitors cumulative privacy loss across training rounds

The algorithmic creation of artificial datasets that statistically mimic real patient records. Federated GANs extend this capability across institutions by training generators locally while sharing only model parameters. This enables:

• Rare disease modeling: Augmenting limited local cases with synthetic samples
• Cross-institutional research: Sharing synthetic cohorts without data use agreements
• Regulatory compliance: Training on synthetic data that falls outside HIPAA scope

An adversarial technique that determines whether a specific patient's record was used in training. In federated GAN contexts, attackers analyze discriminator outputs or generated samples to infer training set membership. Defenses include:

• Differential privacy integration in the discriminator
• Dropout and regularization to reduce overfitting
• Generated sample auditing before cross-institutional sharing Understanding this threat is critical for validating that federated GANs truly protect patient privacy.

A quantitative measure of how well synthetic data preserves statistical relationships and predictive performance. For Federated GANs, utility is evaluated using:

• Train-Synthetic-Test-Real (TSTR): Models trained on synthetic data must perform well on real holdout sets
• Column-wise distribution fidelity: Kolmogorov-Smirnov tests between real and synthetic features
• Correlation preservation: Pairwise feature relationships must be maintained High utility ensures synthetic cohorts are viable substitutes for real data in clinical research.

A change in statistical properties of data over time that degrades model performance. In Federated GANs, distributional shift manifests as:

• Site-specific drift: Local patient demographics evolving differently across hospitals
• Concept drift: Changing relationships between clinical features and outcomes
• Covariate shift: Differences in input distributions between training and deployment Continuous monitoring and adaptive retraining strategies are essential for maintaining synthetic data quality in dynamic clinical environments.